BMKDF
Price:
$0.3549
Market Cap:
$49.39M
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Industry
Medical - Diagnostics & Research
IPO Date
2015-03-23
Stock Exchange
OTC
Ticker
BMKDF
According to BioMark Diagnostics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -35.49. This represents a change of 149.25% compared to the average of -14.24 of the last 4 quarters.
The mean historical PE Ratio of BioMark Diagnostics Inc. over the last ten years is -11.63. The current -35.49 PE Ratio has changed 30.43% with respect to the historical average. Over the past ten years (40 quarters), BMKDF's PE Ratio was at its highest in in the March 2016 quarter at -2.64. The PE Ratio was at its lowest in in the September 2023 quarter at -29.68.
Average
-11.63
Median
-10.00
Minimum
-28.14
Maximum
-5.14
Discovering the peaks and valleys of BioMark Diagnostics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.46%
Maximum Annual PE Ratio = -5.14
Minimum Annual Increase = -59.34%
Minimum Annual PE Ratio = -28.14
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -11.94 | -33.34% |
| 2024 | -17.91 | 89.86% |
| 2023 | -9.44 | -17.51% |
| 2022 | -11.44 | -59.34% |
| 2021 | -28.14 | 166.46% |
| 2020 | -10.56 | 34.48% |
| 2019 | -7.85 | 18.14% |
| 2018 | -6.65 | -7.62% |
| 2017 | -7.20 | 40.01% |
| 2016 | -5.14 | 45.80% |
The current PE Ratio of BioMark Diagnostics Inc. (BMKDF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-13.10
5-year avg
-15.77
10-year avg
-11.63
BioMark Diagnostics Inc.’s PE Ratio is less than Cordlife Group Limited (-3.03), less than Izotropic Corporation (-6.32), less than Marpai, Inc. (-0.99), less than ImpediMed Limited (-3.99), less than DIAGNOS Inc. (-7.18), less than Fluent Corp. (-0.35), less than Evolva Holding S.A. (-6.64), less than Celyad Oncology S.A. (-1.18), less than Rubicon Organics Inc. (126.87), less than Starpharma Holdings Limited (-16.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.03 | $26.11M | |
| -6.32 | $16.65M | |
| -0.99 | $11.99M | |
| -3.99 | $24.04M | |
| -7.18 | $24.78M | |
| -0.35 | $19.10M | |
| -6.64 | $7.93M | |
| -1.18 | $8.06M | |
| 126.87 | $22.30M | |
| -16.54 | $87.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMark Diagnostics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioMark Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioMark Diagnostics Inc.'s PE Ratio?
How is the PE Ratio calculated for BioMark Diagnostics Inc. (BMKDF)?
What is the highest PE Ratio for BioMark Diagnostics Inc. (BMKDF)?
What is the 3-year average PE Ratio for BioMark Diagnostics Inc. (BMKDF)?
What is the 5-year average PE Ratio for BioMark Diagnostics Inc. (BMKDF)?
How does the current PE Ratio for BioMark Diagnostics Inc. (BMKDF) compare to its historical average?